168 related articles for article (PubMed ID: 12165492)
1. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice.
McVicar DW; Winkler-Pickett R; Taylor LS; Makrigiannis A; Bennett M; Anderson SK; Ortaldo JR
J Immunol; 2002 Aug; 169(4):1721-8. PubMed ID: 12165492
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
Mason LH; Willette-Brown J; Taylor LS; McVicar DW
J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
[TBL] [Abstract][Full Text] [Related]
3. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H.
Gosselin P; Mason LH; Willette-Brown J; Ortaldo JR; McVicar DW; Anderson SK
J Leukoc Biol; 1999 Jul; 66(1):165-71. PubMed ID: 10411005
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of a novel activating Ly49 closely related to Ly49A.
Makrigiannis AP; Gosselin P; Mason LH; Taylor LS; McVicar DW; Ortaldo JR; Anderson SK
J Immunol; 1999 Nov; 163(9):4931-8. PubMed ID: 10528196
[TBL] [Abstract][Full Text] [Related]
5. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
[TBL] [Abstract][Full Text] [Related]
6. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
[TBL] [Abstract][Full Text] [Related]
7. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
[TBL] [Abstract][Full Text] [Related]
8. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
[TBL] [Abstract][Full Text] [Related]
9. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.
Tomasello E; Desmoulins PO; Chemin K; Guia S; Cremer H; Ortaldo J; Love P; Kaiserlian D; Vivier E
Immunity; 2000 Sep; 13(3):355-64. PubMed ID: 11021533
[TBL] [Abstract][Full Text] [Related]
10. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
[TBL] [Abstract][Full Text] [Related]
12. Recognition of CHO cells by inhibitory and activating Ly-49 receptors.
Mason LH
J Leukoc Biol; 2000 Oct; 68(4):583-6. PubMed ID: 11037982
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
Tassi I; Presti R; Kim S; Yokoyama WM; Gilfillan S; Colonna M
J Immunol; 2005 Jul; 175(2):749-54. PubMed ID: 16002670
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
Held W; Cado D; Raulet DH
J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
[TBL] [Abstract][Full Text] [Related]
16. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
Lowin-Kropf B; Kunz B; Schneider P; Held W
Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins.
Makrigiannis AP; Etzler J; Winkler-Pickett R; Mason A; Ortaldo JR; Anderson SK
J Leukoc Biol; 2000 Nov; 68(5):765-71. PubMed ID: 11073118
[TBL] [Abstract][Full Text] [Related]
18. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
Fahlén L; Lendahl U; Sentman CL
J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
McVicar DW; Burshtyn DN
Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]